Filed before 2025Filed 26 February 2020
Neurana Pharmaceuticals, Inc. has sold $41.9M so far
Neurana Pharmaceuticals, Inc., a biotech company based in San Diego, CA, has sold $41.9M so far in its equity round, according to a filing dated 26 February 2020.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 26 February 2020
- First filed
- 14 May 2018
- Round
- Equity round (amended filing)
- Amount sold
- $41.9M
- Offering size
- $64.9M
- Investors so far
- 14
- Based in
- San Diego, CA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 86% of the 1,744 tracked raises with an amount filed in 2020, and than 72% of the 152 in biotech.
Neurana Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 26 Feb 2020 | Amended filing | $41.9M | This raise |
| 14 May 2018 | New filing | $29.9M | This raise |
| 14 May 2018 | Amended filing | $3.82M | Another raise |
More with HealthQuest on the board
- 83Bar, Inc.$7.5M
- Solaborate Inc.$47M
- Venus Concept Inc.$1.1M
- Home Hospital Newco, Inc.$30M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.